Report Overview
The size of the world market for medication management, which was anticipated to be worth US$ 2,469.34 million in 2022, is predicted to increase to US$ 10,129.43 million by 2030, rising at a CAGR of 20.00% over the forecast period (2023-2030).
Medication management is a method of informing patients and carers in order to compile an accurate and complete list of all the medications taken. The first step in resolving medication reconciliation and management issues is to create a comprehensive and accurate prescription list. Additionally, these techniques can aid in the identification of actions that may put patients at risk for drug-related adverse events, such as taking medications in excess or insufficiently, forgetting to do so, or engaging in other risky behaviours.
For More Insights request free Sample: https://www.datamintelligence.com/download-sample/medication-management-market
Market Dynamics
A growing number of hospitals are investing more money in cutting-edge technology, which is one of the main factors propelling the global market for medication management. The industry is also expected to expand quickly as the number of prescriptions written globally rises.
Product introductions by industry players are assisting the market's expansion.
Market growth is anticipated to be fueled by increased investments in the introduction of new products, enhanced healthcare process management, and decreased prescription error.
For instance, the Medication Management Assistance Mini Programme on WeChat (the "Programme") was introduced in January 2023 by Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), one of the China operating entities with which the Company consolidates the financial results through certain contractual arrangements. The announcement was made by Zhongchao Inc., a platform-based internet technology business that offers services to people with oncology and other critical conditions. Zhongxin designed the Programme to guide cancer patients through and get over medication issues.
Additionally, in November 2020, the Boston, Massachusetts-based digital therapeutics companion platform Medisafe announced that its ground-breaking Medisafe Maestro platform would be put into immediate use. This cutting-edge solution creates personalised patient care resources that are supplied via a digital drug companion, orchestrating medication adherence journeys with accuracy and speed. Through its integrated Care Connector, Medisafe offers the pharmaceutical sector digital patient care resources, enabling real-time patient interaction and customised digital medication companions.
The market's expansion is anticipated to be hampered by a lack of awareness.
Other barriers to the market's expansion for drug management systems, however, include poor countries' low awareness of these systems and their higher costs.
View Full Report: https://www.datamintelligence.com/research-report/medication-management-market
Medication Management Market Companies
Key players are GE Healthcare, QUALCOMM Incorporated, Omnicell, Inc, Talyst, LLC, Allscripts Healthcare Solutions Inc., ARxIUM, Becton Dickinson and Company, Cerner Corporation, QuadraMed Affinity Corporation, McKesson Corporation and more.
Related Reports:
Sign in to leave a comment.